PreciThera Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

PreciThera General Information

Description

Operator of a biotechnology company intended to treat rare bone diseases. The company's medicines mainly focus on heterogeneous genetic disorders that primarily manifest in bone dysfunction using the combined application of computational technology and a deep understanding of disease pathology to meaningfully impact both the skeletal symptoms as well as the extraskeletal issues, enabling patients to get treated via traditional protein replacement therapies.

Contact Information

Website
www.precithera.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1010 Sherbrooke Street West
  • Suite 408
  • Montreal, Quebec H3A 2R7
  • Canada
+1 (514)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 1010 Sherbrooke Street West
  • Suite 408
  • Montreal, Quebec H3A 2R7
  • Canada
+1 (514)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PreciThera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 24-Jun-2022 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 27-Jul-2017 Completed Pre-Clinical Trials
1. Seed Round 10-May-2017 Completed Pre-Clinical Trials
To view PreciThera’s complete valuation and funding history, request access »

PreciThera Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to treat rare bone diseases. The company's medicines mainly focus on hetero
Drug Discovery
Montreal, Canada
2 As of 2025

Burlington, MA
 

Westminster, CO
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PreciThera Competitors (2)

One of PreciThera’s 2 competitors is Bone Biologics, a Corporation company based in Burlington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bone Biologics Corporation Burlington, MA
Cerapedics Venture Capital-Backed Westminster, CO
You’re viewing 2 of 2 competitors. Get the full list »

PreciThera Patents

  • 8

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

PreciThera Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190248881-A1 Tgf-ß receptor fusion proteins and other tgf-ß antagonists for reducing tgf-ß signaling Inactive 04-Dec-2017
WO-2019113123-A1 Tgf-ß receptor fusion proteins and other tgf-ß antagonists for reducing tgf-ß signaling Inactive 04-Dec-2017
EP-3496755-A1 Tgf- antagonist conjugates Inactive 11-Aug-2016
EP-3496755-A4 Tgf- antagonist conjugates Inactive 11-Aug-2016
CA-3033614-A1 Tgf-.beta. antagonist conjugates Inactive 11-Aug-2016 C07K14/495
To view PreciThera’s complete patent history, request access »

PreciThera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PreciThera Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Crédit Mutuel Equity Growth/Expansion Minority
CTI Life Sciences Fund Venture Capital Minority
Fonds de solidarite FTQ PE/Buyout Minority
Sanderling Ventures Venture Capital Minority
To view PreciThera’s complete investors history, request access »

Ready to get started?

Request a free trial

PreciThera FAQs

  • When was PreciThera founded?

    PreciThera was founded in 2016.

  • Where is PreciThera headquartered?

    PreciThera is headquartered in Montreal, Canada.

  • What is the size of PreciThera?

    PreciThera has 2 total employees.

  • What industry is PreciThera in?

    PreciThera’s primary industry is Drug Discovery.

  • Is PreciThera a private or public company?

    PreciThera is a Private company.

  • What is PreciThera’s current revenue?

    The current revenue for PreciThera is .

  • How much funding has PreciThera raised over time?

    PreciThera has raised $36M.

  • Who are PreciThera’s investors?

    Crédit Mutuel Equity, CTI Life Sciences Fund, Fonds de solidarite FTQ, and Sanderling Ventures have invested in PreciThera.

  • Who are PreciThera’s competitors?

    Bone Biologics and Cerapedics are competitors of PreciThera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process